Aurora Cannabis (ACB) EBIT (2017 - 2026)

Aurora Cannabis (ACB) has reported EBIT for 10 consecutive years, with $7.3 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, EBIT rose 73.26% year-over-year to $7.3 million in Q2 2026; TTM through Jun 2026 was $27.1 million, a 124.51% increase from a year earlier, with the FY2026 full-year figure at -$33.8 million, down 1048.62% from the prior year.
• EBIT was $7.3 million for Q2 2026 at Aurora Cannabis, up from $3.0 million in the prior quarter.
• Over five years, EBIT peaked at $26.4 million in Q4 2024 and troughed at -$129.2 million in Q4 2022.
• A 5-year average of -$16.6 million and a median of -$717248.9 in 2024 frame the typical range for EBIT.
• The widest YoY moves for EBIT: up 686.33% in 2025, down 841.31% in 2025.
• Over 5 years, EBIT stood at -$129.2 million in 2022, then jumped by 90.0% to -$12.9 million in 2023, then surged by 304.13% to $26.4 million in 2024, then slumped by 46.83% to $14.0 million in 2025, then slumped by 48.05% to $7.3 million in 2026.
• The last three EBIT figures came in at $7.3 million (Q2 2026), $3.0 million (Q1 2026), and $14.0 million (Q4 2025), per Business Quant data.